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Letters to the Editor
Concentration of Testosterone Glucuronide in Urine from Women with Breast
Tumours. M. K. JONES, I. D. RAMSAY AND W. P. COLLINS Br. J. Cancer (1977) 35, 885.
SrR,-In a high proportion of women with
benign breast disease the androgenic activity
is abnormal and the premenstrual endo-
metrium hyperplastic (R. Grattarola, Senolo-
gia (1977) 2, 19). As the result of this studyI
suggested that abnormal androgenicity might
be the hormonal condition for converting a
benign to a malignant breast disease; so I am
not surprised when the authors of this paper
claim that there is no difference in the con-
centration of the testosterone glucuronide
from patients with benign or malignant
breast disease. What surprises me is their
conclusion; that their results, which come
from two groups of women with either
benign or malignant tumours of the breast,
do not concur with my results, which showed
that in women with breast cancer and hyper-
plastic endometrial pattern, the amount of
testosterone excreted is above that of women
whose breast was free from any disease, as
ascertained by clinical and mammographic
examinations, and whose endometrial pattern
was normal.
The comparison made in this study is
clearly quite different from mine and con-
sequently the conclusions must be different
too.
3 October 1977
RENZO GRATTAROLA
Director, Hormone Research Laboratory,
Istituto Nazionale per lo Studio e la Cura
dei Tumori, via Venezian. 1, Milan.
SIR,-Dr Grattarola's hypothesis is that
androgens play an important part in the
development and progression of breast
cancer; to investigate this he has determined
the concentration of urinary testosterone
glucuronide by gas-chromatography in
groups of women with breast cancer, and
found it abnormal. In the study referred to
in his letter he claims androgenic activity is
also abnormal in benign disease, and suggests
that this stimulus is responsible for con-
verting benign disease to malignant. I
cannot support this conclusion. We measured
testosterone glucuronide by radioimmuno-
assay in patients with benign and malignant
disease of the breast. The results show that
the concentrations were not significantly
different; in addition all the values were
within the accepted normal laboratory range
for this technique.
Stress is known to effect the excretion of
urinary steroid metabolites. I consider the
control group ofsimilarlyhospitalized women
with benign breast disease to be particularly
appropriate.
21 October 1977
M. K. JONES
Department of Medicine, The Middlesex
Hospital, London WIN 8AA